Rory B. Riggs - 19 May 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: Director
Signature: /s/ Jason Mehar, as Attorney-in-Fact for Rory B. Riggs
Issuer symbol: RPRX
Transactions as of: 19 May 2022
Net transactions value: -$5,913,306
Form type: 4
Filing time: 23 May 2022, 16:55:38 UTC
Previous filing: 04 Apr 2022
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	$1,054,651	-26,304	-4.4%	$40.09	575,408	19 May 2022	Direct	F1
transaction	RPRX	Class A Ordinary Shares	Sale	$4,858,655	-123,696	-21%	$39.28	451,712	20 May 2022	Direct	F2
holding	RPRX	Class A Ordinary Shares						85,187	19 May 2022	By New Ventures III LLC
holding	RPRX	Class A Ordinary Shares						15,000	19 May 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.